M2 macrophages or IL-33 treatment attenuate ongoing Mycobacterium tuberculosis infection (2017)
- Authors:
- USP affiliated authors: RUSSO, MOMTCHILO - ICB ; BONATO, VANIA LUIZA DEPERON - FMRP ; ALVES FILHO, JOSÉ CARLOS FARIAS - FMRP ; RAMOS, SIMONE GUSMÃO - FMRP
- Unidades: ICB; FMRP
- DOI: 10.1038/srep41240
- Subjects: IMUNOLOGIA; ALÉRGENOS; INTERLEUCINAS; MACRÓFAGOS; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSE PULMONAR
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Scientific Reports
- ISSN: 2045-2322
- Volume/Número/Paginação/Ano: v. 7, n. 41240, p. 1-12, 2017
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
PIÑEROS, A. R. et al. M2 macrophages or IL-33 treatment attenuate ongoing Mycobacterium tuberculosis infection. Scientific Reports, v. 7, n. 41240, p. 1-12, 2017Tradução . . Disponível em: https://doi.org/10.1038/srep41240. Acesso em: 28 mar. 2024. -
APA
Piñeros, A. R., Campos, L. W., Fonseca, D. M. da, Bertolini, T. B., Gembre, A. F., Prado, R. Q., et al. (2017). M2 macrophages or IL-33 treatment attenuate ongoing Mycobacterium tuberculosis infection. Scientific Reports, 7( 41240), 1-12. doi:10.1038/srep41240 -
NLM
Piñeros AR, Campos LW, Fonseca DM da, Bertolini TB, Gembre AF, Prado RQ, Alves Filho JCF, Ramos SG, Russo M, Bonato VLD. M2 macrophages or IL-33 treatment attenuate ongoing Mycobacterium tuberculosis infection [Internet]. Scientific Reports. 2017 ; 7( 41240): 1-12.[citado 2024 mar. 28 ] Available from: https://doi.org/10.1038/srep41240 -
Vancouver
Piñeros AR, Campos LW, Fonseca DM da, Bertolini TB, Gembre AF, Prado RQ, Alves Filho JCF, Ramos SG, Russo M, Bonato VLD. M2 macrophages or IL-33 treatment attenuate ongoing Mycobacterium tuberculosis infection [Internet]. Scientific Reports. 2017 ; 7( 41240): 1-12.[citado 2024 mar. 28 ] Available from: https://doi.org/10.1038/srep41240 - IFN-'gama'-mediated efficacy of allergen-free immunotherapy using mycobacterial antigens and CpG-ODN
- Recombinant DNA immunotherapy ameliorate established airway allergy in a IL-10 dependent pathway
- CCR4-dependent reduction in the number and suppressor function of CD4+Foxp3+ cells augments IFN-γ-mediated pulmonary inflammation and aggravates tuberculosis pathogenesis
- Mycobacterium tuberculosis culture filtrate proteins plus CpG oligodeoxynucleotides confer protection to mycobacterium bovis BCG-primed mice by inhibiting interleukin-4 secretion
- Oral administration of Saccharomyces cerevisiae UFMG A‐905 prevents allergic asthma in mice
- Modulação da resposta alérgica e da resposta imune na Tuberculose
- Systemic immunological changes in patients with distinct clinical outcomes during Mycobacterium tuberculosis infection
- Systemic infection by non-albicans Candida species affects the development of a murine model of multiple sclerosis
- Requirement of MyD88 and Fas pathways for the efficacy of allergen-free immunotherapy
- Protection conferred by heterologous vaccination against tuberculosis is dependent on the ratio of CD4+/ CD4+ Foxp3+ cells
Informações sobre o DOI: 10.1038/srep41240 (Fonte: oaDOI API)
Download do texto completo
Tipo | Nome | Link | |
---|---|---|---|
002909222.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas